KTTA Pasithea Therapeutics Corp. - Common Stock
$0.71
Price · May 20, 2026
52W Range
$0–$2
24% of range
Analyst Rating
BUY
7 analysts
Price Target
$3
+320% upside
P/E (TTM)
—
ROE
—
Net Profit Margin
—
KTTA Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$0.71
Market Cap
—
P/E (TTM)
—
EPS (TTM)
—
Revenue (TTM)
—
Div Yield
—
ROE
—
Debt/Equity
—
52W Range
$0 – $2
KTTA Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
10-Year Performance Revenue, net income, margins and EPS trends
Revenue & Net Income
—
EPS
—
Free Cash Flow
—
Margins
—
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
KTTA
Peer Median
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
KTTA
Peer Median
Financial Health Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
KTTA
Peer Median
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
KTTA
Peer Median
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
KTTA
Peer Median
KTTA Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
BUY
7 analysts
- Strong Buy 2 28.6%
- Buy 4 57.1%
- Hold 1 14.3%
- Sell 0 0.0%
- Strong Sell 0 0.0%
12-Month Price Target
1 analysts · 2026-05-14
Low
$3.00
High
$3.00
Median target
$3.00
+320.5%
Mean target
$3.00
+320.5%
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
0.54%
| Period | EPS Actual | EPS Est | Surprise |
|---|---|---|---|
| March 31, 2026 | $-0.12 | $-0.46 | 0.34% |
| Dec. 31, 2025 | $-0.79 | $-0.18 | -0.61% |
| Dec. 31, 2024 | $-2.41 | — | — |
| March 31, 2022 | $-1.40 | $-0.41 | -0.99% |
| Dec. 31, 2021 | $2.40 | $-1.02 | 3.4% |
Peer Comparison Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| KTTA | — | — | — | — | — | — |
| AIXC | $12M | -0.3 | — | — | -110.8% | — |
| VTGN | — | -1.5 | -54.3% | -10579.8% | -67.9% | — |
| CLRB | — | -0.4 | — | — | — | — |
| JSPR | — | -0.5 | — | — | — | — |
| SNSE | $13M | -0.6 | — | — | -91.9% | — |
| GRDX | $20M | -1.1 | — | -17634.4% | -68.6% | -1813.6% |
| CELU | $32M | -0.3 | -51.0% | -345.4% | 288.6% | — |
| MRKR | $25M | -1.9 | -46.2% | -343.0% | -89.1% | — |
| ALLR | $17M | -0.0 | — | -3509.7% | -102.1% | — |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
📊
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.